p16INK4A (CDKN2A) Mouse Monoclonal Antibody [Clone ID: OTI1H3]
CAT#: CF801624
Carrier-free (BSA/glycerol-free) CDKN2A mouse monoclonal antibody, clone OTI1H3 (formerly 1H3)
Formulation: Standard
View other "OTI1H3" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
CNY 3,999.00
Specifications
Product Data | |
Clone Name | OTI1H3 |
Applications | IHC |
Recommend Dilution | IHC 1:150 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Full length human recombinant protein of human CDKN2A (NP_000068) produced in HEK293T cell. |
Formulation | Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) |
Reconstitution Method | For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 16.4 kDa |
Gene Name | cyclin dependent kinase inhibitor 2A |
Database Link | |
Background | This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012] |
Synonyms | ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4 |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Bladder cancer, Cell cycle, Chronic myeloid leukemia, Glioma, Melanoma, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Pathways in cancer |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
TA801624 | CDKN2A mouse monoclonal antibody, clone OTI1H3 (formerly 1H3) |
CNY 1,999.00 |
|
TA801624AM | CDKN2A mouse monoclonal antibody, clone OTI1H3 (formerly 1H3), Biotinylated |
CNY 3,990.00 |
|
TA801624BM | CDKN2A mouse monoclonal antibody, clone OTI1H3 (formerly 1H3), HRP conjugated |
CNY 3,990.00 |
|
TA801624S | CDKN2A mouse monoclonal antibody, clone OTI1H3 (formerly 1H3) |
CNY 800.00 |
其它p16INK4A产品